<DOC>
	<DOCNO>NCT01962194</DOCNO>
	<brief_summary>The investigator hypothesize emotional cognitive area Subthalamic Nucleus ( STN ) distinct electrophysiological property specific stimulation area influence mental emotional state . Parkinson 's disease ( PD ; n=5 ) obsessive-compulsive disorder ( OCD ; n=5 ) patient candidate treatment Subthalamic Nucleus ( STN ) Deep Brain Stimulation ( DBS ) recruit period two year . The patient enrol prospective , open label , clinical trial follow one year . No randomization blind use study .</brief_summary>
	<brief_title>Mapping Stimulating Limbic Areas Subthalamic Nucleus</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion PD patient : 1 . Patients PD meet accept criterion DBS surgery : i. advance idiopathic PD ii . longterm levodopa use lead decreased efficacy increase incidence adverse effect iii . normal cognitive function mildmoderate cognitive decline ( Addenbrooke 's Cognitive Examination ( ACE ) &gt; 75 Frontal Assessment Battery ( FAB ) &gt; 10 . 2 . Age 4075 year 3 . Male female 4 . Competent willing give write informed consent Exclusion Criteria PD patient : 1 . A diagnosis severe major depression disorder ( MDD ) psychotic feature 2 . Significant suicidal risk [ Hamilton Depression scale item 3 ( suicide ) &gt; 2 ] 3 . Lifetime history substance alcohol dependence abuse precede 12 month 4 . Significant cognitive decline , measure Addenbrooke 's Cognitive Examination ( ACE ) &lt; 75 Frontal Assessment Battery ( FAB ) &lt; 10 . 5 . Significant cognitive impairment would affect participant 's ability give inform consent provide interview selfreport data reliably 6 . Any clinically significant abnormality preoperative MRI 7 . Any DBS contraindication , infection , coagulopathy , significant cardiac risk factor , medical risk factor surgery 8 . Pregnant and/or woman childbearing age use effective form birth control Inclusion criterion OCD patient : 1 . Obsessivecompulsive disorder ( OCD ) , diagnose Structured Clinical Interview Diagnostic Statistical Manual Mental Disorders ( DSMIV ) ( SCIDIV ) 2 . Presence disable severity , assess YaleBrown Obsessive Compulsive Scale ( YBOCS ) score least 25 3 . Documented highly treatment refractory OCD ; documentation must demonstrate persistence severe symptom impairment 5 year despite pharmacological psychological treatment . 4 . Either drug free stable drug regimen least 6 week study entry 5 . General good overall health 6 . Age 2070 year 7 . Male female 8 . Competent willing give write informed consent . Exclusion Criteria OCD patient : 1 . A diagnosis severe major depression disorder ( MDD ) psychotic feature 2 . Significant suicidal risk [ Hamilton Depression scale item 3 ( suicide ) &gt; 2 ] . 3 . Comorbidity primary Psychotic Disorder , Bipolar Disorder , Post Traumatic Stress Disorder ( PTSD ) , Eating Disorder . 4 . Lifetime history substance alcohol dependence abuse precede 12 month 5 . Significant cognitive decline , measure Addenbrooke 's Cognitive Examination ( ACE ) &lt; 75 Frontal Assessment Battery ( FAB ) &lt; 10 . 6 . Significant cognitive impairment would affect participant 's ability give inform consent provide interview selfreport data reliably 7 . Any another current clinically significant neurological disorder medical illness affect brain function , tic disorder 8 . Any clinically significant abnormality preoperative MRI 9 . Any DBS contraindication , infection , coagulopathy , significant cardiac risk factor , medical risk factor surgery 10 . Pregnant and/or woman childbearing age use effective form birth control</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>